Omnicell (OMCL) Up 0.1% Since Last Earnings Report: Can It Continue?

28.05.26 17:30 Uhr

Werte in diesem Artikel
Aktien

34,20 EUR 0,00 EUR 0,00%

Indizes

25.297,6 PKT -61,0 PKT -0,24%

A month has gone by since the last earnings report for Omnicell (OMCL). Shares have added about 0.1% in that time frame, underperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Omnicell due for a pullback? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for Omnicell, Inc. before we dive into how investors and analysts have reacted as of late.Omnicell Q1 Earnings & Revenues Top, Gross Margin RisesOmnicell, Inc. (OMCL) reported first-quarter 2026 adjusted earnings per share (EPS) of 55 cents, up 111.5% year over year. The metric beat the Zacks Consensus Estimate by 67.94%. Adjustments include one-time expenses like share-based compensations, the amortization of acquired intangibles, acquisition-related expenses, executive transition costs and others.GAAP earnings were 25 cents per share in the quarter under review compared to a loss of 15 cents in the prior-year quarter.OMCL’s Revenue DetailsRevenues in the first quarter totaled $310 million, up 15% year over year. This was driven by strength in the connected devices offerings, as well as increases in technical services, SaaS and Expert Services, and consumables revenues. The figure beat the Zacks Consensus Estimate by 2.2%.On a segmental basis, Product revenues rose 20.4% year over year to $174.8 million in the reported quarter. Service revenues climbed 8.5% year over year to $135.1 million.OMCL’s Operational UpdateIn the quarter under review, the gross profit rose 26.5% to $140.4 million. The gross margin expanded 416 basis points (bps) to 45.3% despite a 6.8% rise in the cost of revenues.Operating expenses amounted to $123.5 million, up 0.8% year over year. The operating profit in the quarter totaled $16.8 million compared to an operating loss of $11.6 million in the year-ago quarter.OMCL’s Financial UpdateOmnicell exited the first quarter of 2026 with cash and cash equivalents of $239.2 million compared with $196.5 million at the end of 2025.The cumulative cash flow provided by operating activities at the end of the first quarter was $54.5 million compared with $25.9 million a year ago.Omnicell’s 2026 OutlookFor full-year 2026, the company continues to expect revenues in the range of $1.215-$1.255 billion. Within this, Product revenues are expected to be in the band of $690-$710 million and Service revenues in the range of $525-$545 million. The Zacks Consensus Estimate for total revenues is pegged at $1.24 billion.Adjusted EPS for the full year is expected between $1.80 and $2.00, up from the previous guidance of $1.65-$1.85. The Zacks Consensus Estimate is pegged at $1.77.For the second quarter of 2026, Omnicell expects $307-$313 million in total revenues, comprising Product revenues of $174-$177 million and Service revenues of $133-$136 million. The Zacks Consensus Estimate for second-quarter revenues is pinned at $309.6 million.Adjusted EPS for the second quarter is expected between 40 cents and 48 cents. The Zacks Consensus Estimate is pegged at 41 cents.How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in fresh estimates.The consensus estimate has shifted 60.53% due to these changes.VGM ScoresCurrently, Omnicell has a nice Growth Score of B, though it is lagging a bit on the Momentum Score front with a C. Following the exact same course, the stock was allocated a score of C on the value side, putting it in the middle 20% for this investment strategy.Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Omnicell has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Omnicell und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Omnicell Inc.

Analysen zu Omnicell Inc.

DatumRatingAnalyst
26.07.2019Omnicell BuyCraig Hallum
07.03.2019Omnicell BuyDougherty & Company LLC
29.06.2018Omnicell BuyThe Benchmark Company
05.09.2017Omnicell BuyThe Benchmark Company
28.07.2017Omnicell BuyDougherty & Company LLC
DatumRatingAnalyst
26.07.2019Omnicell BuyCraig Hallum
07.03.2019Omnicell BuyDougherty & Company LLC
29.06.2018Omnicell BuyThe Benchmark Company
05.09.2017Omnicell BuyThe Benchmark Company
28.07.2017Omnicell BuyDougherty & Company LLC
DatumRatingAnalyst
06.03.2009Omnicell holdBB&T Capital Markets
19.12.2008Omnicell averageCaris & Company, Inc.
11.06.2008Omnicell above averageCaris & Company, Inc.
01.02.2008Omnicell averageCaris & Company, Inc.
05.12.2007Omnicell averageCaris & Company, Inc.
DatumRatingAnalyst
22.01.2009Omnicell DowngradeBB&T Capital Markets

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Omnicell Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen